Picard Medical, Inc. (PMI), parent company of SynCardia Systems LLC, highlighted a successful bridge-to-transplant case at UCSF Health using the SynCardia Total Artificial Heart (STAH).
A 37-year-old patient with end-stage biventricular heart failure was admitted in August 2025. Within weeks, UCSF surgeons implanted the SynCardia Total Artificial Heart, marking the hospital's fifth such procedure. Three months later, the patient underwent a successful heart transplant and continues to recover well.
The six-hour procedure was performed at the Helen Diller Medical Center by Dr. Amy Fiedler, Surgical Director of the Heart Transplant and Mechanical Circulatory Support Program, and Dr. Jason W. Smith, Chief of Cardiac Surgery and Lung Transplantation. UCSF Health, ranked the top hospital in California by U.S. News & World Report is the only center in Northern California actively implanting mechanical hearts.
Picard Medical CEO Patrick NJ Schnegelsberg noted that the case underscores growing clinical adoption of the SynCardia Total Artificial Heart, which stabilizes patients until a donor heart becomes available. The company is also advancing development of the Emperor TAH, a next-generation fully implantable device designed for long-term support.
PMI has traded between a low of $1.39 and a high of $13.68. The stock is currently trading at $1.73, up 8%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.